Biologics Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Report Description<br />
Request Free Report Sample@<br />
http://www.futuremarketinsights.com/reports/sample/rep-gb-1249<br />
In terms of geography, North America and Europe dominate the market, followed by<br />
Asia-Pacific. However, rising technological advancement in healthcare and systematic<br />
drug review process will drive the markets over North America, Japan and other regions.<br />
Europe currently dominates the biosimilars market driven by technically advanced<br />
healthcare infrastructure and high patient awareness & regulatory harmonization.<br />
Increasing funding for development of biologics available through public-private<br />
partnerships, availability of high-quality research infrastructure and innovative strategies<br />
developed by drug makers to restrict entry of new players are factors expected to<br />
contribute to market growth of biologics over the forecast period. Emerging markets<br />
include Eastern European countries followed by countries in Eastern Africa. Rising disease<br />
incidences in these countries is expected to prove favorable for the growth of the<br />
biologics market.<br />
Download TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1249<br />
<strong>Biologics</strong> <strong>Market</strong>: Key Players<br />
Some of the key players in biologics market are Unilife Corporation, Retractable<br />
Technologies, Inc., Smiths Medicals, Becton, Dickinson & Company, Smiths Medical,<br />
Terumo Corporation, Pfizer Inc. (AC. Hospira), Roche Diagnostics, AstraZeneca, Bayer AG,<br />
Genzyme, GSK Biologicals, Lundbeck, Novartis AG, and Merck KGaA.
Change language